Delivery Order 75F40120D00039-75F40120F19001
- Not listed
- The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, was awarded a $3,567,988.74 time and materials delivery order contract by the Food and Drug Administration (FDA) to provide support for the FDA's Community Engagement and Development Initiative. This contract, which does not have a set-aside designation, will run through March 7, 2025. As a leading research institution, Columbia University has extensive experience conducting biomedical...
- This is a firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The contract, worth $243,473.00, is for a "Systematic Review of Neurodevelopmental Outcome in Vulnerable Pediatric Patient Populations" (BAAFDA-24-00123, referencing FY24C3DP2). This contract has no set-aside designation and is expected to be completed by March 7, 2025. As a...
- The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price purchase order to The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division. The $360,905 contract is for studies on hair loss (alopecia) associated with the use of cosmetic hair products and ingredients. The contract does not utilize a set-aside designation. As a private university, Columbia University conducts biomedical research, healthcare...
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $749,000 firm fixed price contract to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division. The contract, awarded on March 30, 2022, is for the VirCapSeq: A Platform for Detection of Pandemic Threats and Differential Diagnosis of Infectious Diseases project under AOI #10 NGS-Based Agnostic Diagnostic, with a completion date...
- The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, was awarded a $744,000.00 cost-reimbursement contract by a U.S. government agency for biomedical research services. This definitive contract has a completion date of September 30, 2004 and was awarded on April 1, 2001. The contract is not associated with a larger vehicle and does not have a set-aside designation. As a leading research institution, Columbia University has extensive...
- This is a definitive, firm fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to The Trustees of Columbia University in the City of New York (Health Sciences Division), a private university and non-profit organization. The $637,675 contract is to adapt Columbia University's platform with micro-sized human tissues into a modular immune chip, by bioengineering adult-like human bone marrow, lung, and heart tissues from...
- This is a $2,205,550.00 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Trustees of Columbia University in the City of New York to provide support for translational and operational science and technology to improve the CDC. The contract has an ultimate completion date of September 12, 2024 and was awarded on September 13, 2022. This contract is not set aside. Columbia University, a leading academic research institution, will leverage...
- The Trustees of Columbia University in the City of New York Sponsored Projects Administration Division (Columbia University) has been awarded a $10.653 million cost-no-fee delivery order contract by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to provide research and experimental services related to geriatric social services. The period of performance is from October 1, 2001 through September 13, 2011. This delivery order was issued under an...
- This is a firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to The Trustees of Columbia University in the City of New York (Columbia University) for an NHSN Adoption Study. The contract has a ceiling value of $371,995.00 and a completion date of September 19, 2018. The contract was not set aside for any specific designation. Columbia University is a renowned private research institution that frequently collaborates with federal agencies through both...
- This is a federal contract award to The Trustees of Columbia University in the City of New York, operating as the Health Sciences Division, by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services. The contract is for a randomized controlled clinical trial to study the efficacy, safety, and acceptability of a female contraceptive product called C31G. The contract has a ceiling value of $902,337.00 and was awarded...
- 75F40120D00039Indefinite Delivery Contract
- 75F40120D00039-75F40120F19001Delivery Order
The Department of Health and Human Services Food and Drug Administration awarded a $1.1 million delivery order to The Trustees of Columbia University in New York, doing business as Columbia University's Health Sciences Division. The order is for the Biosafety Effectiveness and Safety Community Engagement and Development Initiative, a one-year, time and materials contract to support the FDA's efforts to engage communities and develop understanding of biologics effectiveness and safety. As the prime contractor, Columbia University will leverage its expertise in public health and community outreach to deliver services that enhance FDA's dialogue with stakeholders on important issues relating to the agency's evaluation and regulation of biologics.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
CBER Biologics Effectiveness and Safety (BEST): Initiative Community Engagement and Development Initiative | FDA-20-223-SOL-1224066 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 2/3 | 8/13/20, 4:38 PM | |
CBER Biologics Effectiveness and Safety (BEST): Initiative Community Engagement and Development Initiative | FDA-20-223-SOL-1224066 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Pre-Solicitation 1/3 | 8/13/20, 2:32 PM | |
CBER Biologics Effectiveness and Safety (BEST): Initiative Community Engagement and Development Initiative | FDA-20-223-SOL-1224066 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Award Notice 3/3 | 9/30/20, 4:46 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Close Out | ($932k) | 7/28/22 | |
| Not listed | Not listed | $2.0m | 9/30/20 |